1 stories
AI briefings + tags; source links are the ground truth.
About
🇵🇱
Poland
Rzeczpospolita
National & Local
The patent for the most expensive diabetes drug has been revoked. Are cheaper alternatives closer to reimbursement?
A patent for dapagliflozin, a leading diabetes medication, has been revoked, potentially paving the way for cheaper generic versions to be reimbursed in Poland.
Feb 17 • 18:44 UTC